Skip to content

Company information lookup

AVEXA LIMITED (AVX)

Research and development of anti-infective treatments for HIV, Hepatitis C and antibiotic resistant bacteria.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
AVX 0.015 0% 0.014 0.016 0.000 0.000 0.000 0

AVEXA LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code AVX
Securities
Official Listing Date 23 September, 2004
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.avexa.com.au
Registered Office Address Suite 8, Level 1, 61-63 Camberwell Road, HAWTHORN EAST, VIC, AUSTRALIA, 3123
Head Office Telephone (03) 8888 1040
Head Office Fax (03) 8888 1049
Share Registry BOARDROOM PTY LIMITED
LEVEL 7, 207 KENT STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone (02) 9290 9600
Directors / Senior Management
Mr Iain Kirkwood (Chairman)
Dr Jonathan Coates (CEO)
Mr Bruce Hewett (Non Exec. Director)
Mr Allan Tan (Non Exec. Director)
Company Secretary Mr Lee Mitchell
Principal Activities Research and development of anti-infective treatments for HIV, Hepatitis C and antibiotic resistant bacteria.

AVEXA LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
16/12/2014   ATC listed as important option for HIV sufferers 2 PDF
15/12/2014 asterix North Pratt Coal Mine secures first contract 1 PDF
02/12/2014   SPP Documentation 16 PDF
27/11/2014   SPP Timetable 1 PDF
24/11/2014   Results of Meeting 3 PDF
24/11/2014   Avexa 2014 AGM Presentation 18 PDF
24/11/2014 asterix Avexa announces Share Purchase Plan 2 PDF
30/10/2014 asterix Appendix 4C - quarterly 5 PDF
29/10/2014 asterix AIDS Conference highlights ATC as promising new AIDS drug 2 PDF
23/10/2014   Notice of Annual General Meeting/Proxy Form 14 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
18 Dec 2014 0.015 7.14% 0.015 0.014 384,000
17 Dec 2014 0.014 0% 0.014 0.014 236,410
16 Dec 2014 0.014 0% 0.014 0.014 25,000
15 Dec 2014 0.014 0% 0.015 0.014 522,021
12 Dec 2014 0.014 0% 0.014 0.014 378,238

* Volume of shares shown represents only those shares traded on ASX.

AVEXA LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security AVX. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security AVX

Warrants & Structured Products

No warrants & Structured Products are available over the security AVX